Tamarack Advisers, LP

13F Filings History

Latest 13F report
Q4 2023 - Feb 9, 2024
Value $
$2.12M
Signature - Title
Andrew H. Fesler - Chief Compliance Officer
Location
Carlsbad, CA
Summary
This page shows a list of all the recent 13F filings made by Tamarack Advisers, LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Tamarack Advisers, LP reported 1 stock holding with total value $2.12M as of Q4 2023.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2023 1 $2.12M -$45.4M -$45.4M STRM 13F-HR 2/8/2024, 05:42 PM
Q3 2023 40 $154M +$106M -$261M -$156M VTRS, BDX, MDRX, MCK, STRM 13F-HR 11/15/2023, 09:55 PM
Q2 2023 34 $324M +$223M -$19.3M +$203M SPY, TLT, VTRS, MDRX, PHR 13F-HR 8/9/2023, 06:28 PM
Q1 2023 38 $274M +$116M -$19.2M +$96.7M VTRS, MDRX, PHR, STRM, COLL 13F-HR 5/10/2023, 06:06 PM
Q4 2022 36 $194M +$87.1M -$23.5M +$63.6M MDRX, VTRS, PHR, CERS, COLL 13F-HR 2/10/2023, 06:09 PM
Q3 2022 46 $170M +$47.8M -$26.2M +$21.6M LNTH, MDRX, PCRX, PRGO, THC 13F-HR 11/14/2022, 06:12 PM
Q2 2022 41 $173M +$62.9M -$18.8M +$44M CI, LNTH, CERS, PCRX, THC 13F-HR 8/15/2022, 06:39 PM
Q1 2022 45 $204M +$67M -$49.9M +$17.2M CI, PCRX, LNTH, MRK, BVS 13F-HR 5/11/2022, 03:28 PM
Q4 2021 48 $243M +$90.5M -$115M -$24.4M THC, PCRX, MDTXXXX, BVS, SIBN 13F-HR 2/11/2022, 06:04 PM
Q3 2021 36 $312M +$58.4M -$83.4M -$25M HSIC, RIGL, MDTXXXX, PCRX, PDCO 13F-HR 11/10/2021, 06:30 PM
Q2 2021 40 $349M +$68.2M -$235M -$167M MDTXXXX, RIGL, HSIC, PCRX, TPB 13F-HR 8/12/2021, 08:08 PM
Q1 2021 54 $482M +$128M -$161M -$33.3M PCRX, MDTXXXX, RIGL, PDCO, TPB 13F-HR 5/11/2021, 08:31 PM
Q4 2020 45 $480M +$142M -$20.7M +$121M PCRX, MDTXXXX, UTHR, RIGL, NUAN 13F-HR 2/9/2021, 04:32 PM
Q3 2020 35 $324M +$62.5M -$56.7M +$5.83M PCRX, MDTXXXX, HOLX, PRGO, RIGL 13F-HR 11/10/2020, 07:19 PM
Q2 2020 33 $359M +$110M -$56.8M +$53.5M PCRX, DGX, PRGO, UTHR, HOLX 13F-HR 8/10/2020, 06:07 PM
Q1 2020 31 $264M +$83M -$98.9M -$15.9M DGX, MDTXXXX, ATRC, MDRX, PRGO 13F-HR 5/14/2020, 01:48 PM
Q4 2019 29 $438M +$88.1M -$44.7M +$43.5M MDTXXXX, BIO, MDRX, ATRC, PCRX 13F-HR 2/10/2020, 07:48 PM
Q3 2019 31 $384M +$91.2M -$10M +$81.2M MDRX, MDTXXXX, BIO, PCRX, PTLA 13F-HR 11/5/2019, 02:42 PM
Q2 2019 20 $319M +$101M -$19.1M +$81.9M MDRX, MDTXXXX, BIO, PCRX, SRCL 13F-HR 8/12/2019, 04:58 PM
Q1 2019 22 $252M +$66.4M -$16.3M +$50.2M MDRX, MDTXXXX, SRCL, PTLA, LNTH 13F-HR 5/13/2019, 03:29 PM
Q4 2018 20 $223M +$43.1M -$12M +$31M MDRX, MDTXXXX, NUVA, ATRC, NXTM 13F-HR 2/11/2019, 04:25 PM
Q3 2018 29 $317M +$63.7M -$14.3M +$49.3M NUVA, LH, MDRX, MDTXXXX, SRCL 13F-HR 11/13/2018, 12:26 PM
Q2 2018 28 $264M +$119M -$1.81M +$117M MDTXXXX, NUVA, MDRX, LH, OPTN 13F-HR 8/14/2018, 12:53 PM
Q1 2018 27 $210M +$105M -$17.5M +$87.1M NVCR, NUVA, MDRX, MDT, CORI 13F-HR 5/7/2018, 08:11 PM
Q4 2017 32 $162M +$47.7M -$33.6M +$14.1M MDRX, PCRX, LH, NUVA, MDTXXXX 13F-HR 2/13/2018, 05:52 PM
Q3 2017 32 $149M +$47.3M -$11M +$36.4M MDRX, NKTR, MDTXXXX, CORI, GILD 13F-HR 11/13/2017, 12:33 PM
Q2 2017 34 $156M +$31.7M -$18.6M +$13.1M MDRX, NKTR, LH, PCRX, SPNC 13F-HR 8/7/2017, 06:30 PM
Q1 2017 28 $145M +$53.7M -$15.8M +$37.9M MDRX, PCRX, NKTR, GILD, SPNC 13F-HR 5/12/2017, 03:55 PM
Q4 2016 25 $134M +$36M -$95.1M -$59.1M ARIA, NXTM, HOLX, BIO, PCRX Restatement 2/16/2017, 02:04 PM
Q3 2016 37 $315M ELGX, NXTM, PDCO, ARIA, BIO New Holdings 11/9/2016, 05:44 PM
Q3 2016 37 $315M +$116M -$36.3M +$79.9M ELGX, NXTM, PDCO, ARIA, BIO 13F-HR 11/8/2016, 06:01 PM
Q2 2016 26 $255M +$62.2M -$89.6M -$27.4M ELGX, NXTM, IMPR, ARIA, DGX 13F-HR 8/12/2016, 05:49 PM
Q1 2016 21 $286M +$35.4M -$92M -$56.6M ELGX, DGX, PDCO, NXTM, MDRX 13F-HR 5/13/2016, 08:04 PM
Q4 2015 31 $760M SPY, TLT, PDCO, DGX, ELGX 13F-HR 2/8/2016, 02:20 PM